Catalyst Wire Dossier Catalyst Wire Dossier

Naproxen sodium tablets, 220 mg

Naproxen sodium · CVS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naproxen sodium tablets, 220 mg, covering 2019-11-06 to 2019-11-06. Get the full timeline:

Most recent: FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)

See pricing